-
by NaturalNews with a VERY BADsentimentOverall mood: VERY BAD! Postitive adjectives found in the text: willing, scientific, experimental. Negative adjectives found in the text: dangerous, evil, ruthless. Most frequent adjectives: dangerous. Our semantic analysis measures the mood of a post and the author's perspective on a specific topic by analyzing the adjectives present in a text and weighing them appropriately. The purpose of this analysis is to understand how something is being talked about and does not imply a negative or positive judgment. For example, if something unpleasant happens to a celebrity the Sentiment for that post will probably be 'Very bad', but this does not imply that the author has a negative opinion of the person.
August 24, 2010 — (NaturalNews) Back in February, I wrote an article about how a Senate Finance Committee report revealed that GlaxoSmithKline, the maker of the diabetes drug Avandia, knew that its drug was...
-
by Health News
August 21, 2010 — GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta® (belimumab) as a potential treatment for systemic...
-
by PharmaGossip
August 16, 2010 — Just when you thought there was nothing new to say about Avandia, Time magazine reports — citing deputy FDA commissioner Josh Sharfstein — that the agency is investigating whether Glaxo broke the law by holding back from the FDA...
-
August 27, 2010 — The controversy over a GlaxoSmithKline pandemic vaccine is now prompting the European Medicines Agency to conduct a review after a “limited number” of cases of narcolepsy were reported following vaccination. Since last...
-
by WSJ.Com: Health Blog with a VERY GOODsentimentOverall mood: VERY GOOD! Postitive adjectives found in the text: healthy, able. Most frequent adjectives: healthy. Our semantic analysis measures the mood of a post and the author's perspective on a specific topic by analyzing the adjectives present in a text and weighing them appropriately. The purpose of this analysis is to understand how something is being talked about and does not imply a negative or positive judgment. For example, if something unpleasant happens to a celebrity the Sentiment for that post will probably be 'Very bad', but this does not imply that the author has a negative opinion of the person.
August 13, 2010 — Until very recently, if you went to the website of the nonprofit Healthy Lifespan Institute you’d be able to click on a tab to purchase a resveratrol supplement for $540 per year. The tab is gone, and the...
-
in Business by Blogging Stocks
August 12, 2010 — Filed under: Good news , Options , Technical Analysis GlaxoSmithKline ( GSK - option chain ) shares are rising today after the company said an FDA advisory panel unanimously backed its epilepsy drug, ezogabine . GSK...
-
in Science by Daily Finance
August 06, 2010 — Drug-resistant bacteria has become a pressing public health problem, exacting a rising human and financial toll. GlaxoSmithKline announced that it has found a compound that could help attack...
-
by Rxjournals
July 28, 2010 — The National Comprehensive Cancer Network (NCCN) has been awarded two individual $2 million grants from GlaxoSmithKline (GSK) to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the...
-
July 21, 2010 — GlaxoSmithKline reports Q2 loss on legal costs LONDON ? GlaxoSmithKline, the world’s second-largest pharmaceutical company by revenue, on Wednesday reported a loss of 304 million pounds ($464 million) for the...
-
July 19, 2010 — I have not been posting specifically on the FDA Avandia hearings of this past week, focusing rather on some important background that I believed the popular media were missing. The gap was very nicely filled by my esteemed colleague Roy...
-
in Business by PharmaGossip
July 19, 2010 — GlaxoSmithKline profits to be hit by £1.57bn legal bill - Herald Scotland | Business | Markets & Economy : "Drugs giant GlaxoSmithKline’s second-quarter results on Wednesday will see a huge £1.57bn...
-
July 16, 2010 — If you're wrestling with the problem of how to invest your money at a time when the economy is uncertain, the President is unpopular and the Fed is out of ammunition, then how about investing in trouble with a capital T? The stocks I'm thinking...
-
in Business by La Leva di Archimede with a BADsentimentOverall mood: BAD! Postitive adjectives found in the text: scientific, diligent. Negative adjectives found in the text: bad, misleading. Most frequent adjectives: scientific, expert, bad. Our semantic analysis measures the mood of a post and the author's perspective on a specific topic by analyzing the adjectives present in a text and weighing them appropriately. The purpose of this analysis is to understand how something is being talked about and does not imply a negative or positive judgment. For example, if something unpleasant happens to a celebrity the Sentiment for that post will probably be 'Very bad', but this does not imply that the author has a negative opinion of the person.
July 16, 2010 — Adelaide Now From correspondents in Washington: AFP July 14, 2010 Glaxo 'covered up diabetes drug's risks, conducted secret research' BRITISH pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes...
-
in Business by Daily Finance
July 15, 2010 — GlaxoSmithKline's ( GSK ) shares climbed 2.2% in pre-market trading after a majority of the U.S. Food and Drug Administration's panel voted to keep its controversial type 2 diabetes drug Avandia on the U.S. market, albeit...
-
July 15, 2010 — Filed under: Good news , Options , Technical Analysis GlaxoSmithKline ( GSK - option chain ) shares are rising today after the FDA Advisory Committee voted in favor of keeping GSK's diabetes drug Avandia on the market ,...